Department of Health and Social Care (London)
HPV Self-sampling cost effectiveness model
This is a large award for Research & Development — above three-quarters of comparable contracts. Based on 20,405 valued Research & Development tenders in our corpus.
The HPV self-sampling ISE will offer a portion of women eligible for cervical screening in England the choice between a clinician taken sample and a self-sample for HPV.
The UK NSC has appointed the University of Sydney to undertake a piece of cost-effectiveness modelling to understand the conditions under which harms will outweigh benefits for the offer of HPV self-sampling in the UK.
This is particularly important given that testing for HPV on a vaginal/urine self-sample could be slightly less sensitive than a clinician taken cervical sample.
Therefore, modelling is required to understand how the self-sampling offer under different uptake scenarios could impact on the number of screen-detected HPV and treated cervical lesion.
Contract term: 18 months with the option to extend for a period of up to 6 months.
Contract value (including extensions): £249,876 excluding VAT (£29…
What the supplier must deliver
Therefore, modelling is required to understand how
Therefore, modelling is required to understand how the self-sampling offer under different uptake scenarios could impact on the number of screen-detected HPV and treated cervical lesion.
Derived from the notice text — always confirm against the original documents.
- OCID
- 267268b7-446f-4364-b380-c2fc69b6bea3
- Stage
- contract · Contract
- Source
- Contracts Finder
- Buyer ref
- CF-2647900D0O000000rwimUAA
Contains public sector information licensed under the Open Government Licence v3.0. Source data © Crown copyright.